cephalothin has been researched along with Disease Models, Animal in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (87.50) | 18.7374 |
1990's | 2 (8.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Lowy, FD; Steigbigel, NH; Wexler, MA | 1 |
Goldman, PL; Petersdorf, RG | 1 |
Nolan, CM; Ulmer, WC | 1 |
Murray, TW; Sande, MA; Strausbaugh, LJ | 1 |
Brown, IW; Hill, GB; Holland, JA; Osterhout, S; Saltzman, HA; Wolfe, WG | 1 |
McGhee, JR; Michalek, SM | 1 |
Jennings, MM; Jennings, SA; Robson, MC | 1 |
Videau, D | 1 |
Nitzan, D; Walker, CB; Wilkins, TD | 1 |
Murakawa, T; Nishida, M | 1 |
Johnson, ML; Sande, MA | 1 |
Norden, CW | 2 |
Petri, WH | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Blackwood, JM; Brown, CS; Lavigne, JE; Machiedo, GW; Rush, BF | 1 |
Burrous, SE; Eudy, WW; Siedler, AJ | 1 |
Edstrom, LE; Groskin, MG; Krizek, TJ; Robson, MC | 1 |
Demello, FJ; Haglin, JJ; Hitchcock, CR | 1 |
Bawnik, JB; Orda, R; Wiznitzer, T | 1 |
Foret, JD; Haskins, R; Mebust, WK; Valk, WL | 1 |
Chu, WH; Mullen, JL; Rosato, EF; Rosato, FE | 1 |
Bailey, RR; Linton, AL; Turnbull, DI | 1 |
24 other study(ies) available for cephalothin and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Gentamicins; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Rifampin; Staphylococcal Infections; Vancomycin | 1982 |
Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
Topics: Animals; beta-Lactamases; Cefazolin; Cephaloridine; Cephalosporins; Cephalothin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Endocarditis, Bacterial; Enzyme Activation; Female; Male; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1980 |
A study of cephalothin and desacetylcephalothin in cerebrospinal fluid in therapy for experimental pneumococcal meningitis.
Topics: Animals; Cephalothin; Choroid Plexus; Disease Models, Animal; Dose-Response Relationship, Drug; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Streptococcus pneumoniae | 1980 |
Comparative penetration of six antibiotics into the cerebrospinal fluid of rabbits with experimental staphylococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Cephradine; Disease Models, Animal; Leukocyte Count; Male; Meningitis; Methicillin; Nafcillin; Oxacillin; Rabbits; Staphylococcal Infections; Vancomycin | 1980 |
Experimental and clinical experience with hyperbaric oxygen in the treatment of clostridial myonecrosis.
Topics: Adult; Amputation, Surgical; Antitoxins; Bacteroides Infections; Cephalothin; Clindamycin; Clostridium perfringens; Debridement; Disease Models, Animal; Evaluation Studies as Topic; Female; Gas Gangrene; Gentamicins; Humans; Hyperbaric Oxygenation; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Resuscitation; Surgical Wound Infection; Wound Infection | 1975 |
Virulence of Streptococcus mutans: an antibiotic-suppressed rat model for studies of pathogenesis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Carbenicillin; Cephalothin; Chloramphenicol; Dental Caries; Disease Models, Animal; Feces; Mouth; Rats; Streptococcus; Streptococcus mutans; Virulence | 1977 |
Preventing wound infection from distant endogenous sources in the rat.
Topics: Abscess; Animals; Cephalothin; Disease Models, Animal; Drug Administration Schedule; Escherichia coli Infections; Male; Rats; Sepsis; Surgical Wound Infection | 1977 |
[Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefazolin; Cephaloridine; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Injections, Intramuscular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Nitroquinolines; Pyelonephritis; Rats; Rifampin; Sulfamethoxypyridazine; Urine | 1976 |
Chemotherapy of an experimental Bacteroides fragilis infection in mice.
Topics: Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Cephalothin; Chloramphenicol; Clindamycin; Disease Models, Animal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillin G; Tetracycline | 1977 |
Exudate levels and bactericidal activity of cefazolin in a new local infection system using rat granuloma pouches.
Topics: Animals; Bacterial Infections; Cefazolin; Cephalosporins; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Granuloma; Rats | 1977 |
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Penicillins; Rabbits; Rifampin; Staphylococcal Infections; Time Factors; Vancomycin | 1975 |
Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Osteomyelitis; Rabbits; Rifampin; Sisomicin; Staphylococcus aureus | 1975 |
Evaluation of antibiotic-supplemented bone allograft in a rabbit model.
Topics: Animals; Bone Transplantation; Cephalothin; Disease Models, Animal; Mandibular Fractures; Osteomyelitis; Prevotella melaninogenica; Rabbits; Staphylococcus aureus; Tobramycin; Transplantation, Homologous | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
The treatment of experimental peritonitis with intraperitoneal betadine solution.
Topics: Absorption; Animals; Cephalothin; Disease Models, Animal; Escherichia coli Infections; Injections, Intraperitoneal; Iodine; Kanamycin; Peritonitis; Povidone; Povidone-Iodine; Rats; Thyroid Function Tests; Tissue Adhesions | 1974 |
Enhancement of ampicillin efficacy by peroral levodopa in rat pyelonephritis.
Topics: Administration, Oral; Ampicillin; Animals; Catechols; Cephalothin; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Edetic Acid; Escherichia coli Infections; Nitrofurantoin; Phenylacetates; Pyelonephritis; Rats; Time Factors | 1972 |
The efficacy of systemic antibiotics in the treatment of granulating wounds.
Topics: Animals; Anti-Bacterial Agents; Burns; Cephalexin; Cephaloridine; Cephalothin; Disease Models, Animal; Escherichia coli Infections; Granulation Tissue; Kanamycin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Staphylococcal Infections; Wounds and Injuries | 1974 |
Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery, and hyperbaric oxygen.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Clostridium perfringens; Disease Models, Animal; Dogs; Gas Gangrene; Hyperbaric Oxygenation; Penicillins; Prognosis; Tetracycline | 1973 |
Acute necrotizing pancreatitis. An experimental model.
Topics: Acute Disease; Amylases; Animals; Anti-Bacterial Agents; Bacterial Infections; Catheterization; Cattle; Cephalothin; Disease Models, Animal; Guinea Pigs; Injections; Necrosis; Pancreatitis; Spectrophotometry; Taurocholic Acid; Trypsin | 1974 |
The pathophysiology and therapy of empyema in the isolated bladder.
Topics: Animals; Cephalothin; Disease Models, Animal; Dogs; Drainage; Empyema; Female; Male; Postoperative Complications; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Diversion | 1973 |
Peritoneal lavage treatment of experimental pancreatitis.
Topics: Amylases; Animals; Bile Acids and Salts; Cephalothin; Disease Models, Animal; Guinea Pigs; Pancreatitis; Peritoneal Dialysis; Trypsin | 1972 |
Relative nephrotoxicity of cephalosporin antibiotics in an animal model.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Disease Models, Animal; Furosemide; Glycerol; Injections, Subcutaneous; Male; Rats; Rats, Inbred Strains | 1972 |
Experimental osteomyelitis. II. Therapeutic trials and measurement of antibiotic levels in bone.
Topics: Animals; Biological Assay; Bone and Bones; Bone Marrow; Cephalothin; Disease Models, Animal; Hemoglobins; Lincomycin; Osteomyelitis; Rabbits; Sarcina; Time Factors | 1971 |